The Grenoble Alpes University Hospital is a French teaching hospital built in 1974. With a total capacity of over 2 133 beds in 2020, it is the main hospital of Grenoble and Isère in France.

During the past decade, CHU Hotel conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Hotel" #1 collaborator was "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "CHU Hotel" are "Isocitrate Dehydrogenase" (1 trials), "Leukemia, Myeloid" (1 trials), "Multiple Myeloma" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "CHU Hotel" in a lesser frequency.

Most popular intervention types in "CHU Hotel" are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "AG-221" (1 trials), "Azacitidine" (1 trials), "BSC" (1 trials), "Bortezomib" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU Hotel" are 3 trials for "All" genders.

Currently, there are NaN active trials in "CHU Hotel". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CHU Hotel, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHU Hotel, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".